In addition, it turns out, in the pan-cancer analysis, NOLC1 was mutated in a variety of cancers, such as endometrial cancer, gastric cancer, skin melanoma, etc., with only 2.19% (13/594) of the genetic changes in colorectal cancer (Fig. 4b). This evidence concerns the gene NOLC1 and cancer.